The department of pharmaceuticals (DoP) reprimanded AbbVie Healthcare India for unethical marketing practices involving over ₹1 crore spent on foreign vacations for 30 doctors under the guise of conferences in Monaco and Paris. The Central Board of Direct Taxes (CBDT) and National Medical Council are to evaluate the company's tax liability and take action against the healthcare professionals involved.
